AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX216.11-2.47 (-1.13%) ▼|SBUX104.11+1.01 (+0.97%) ▲|SCHW106.44+0.47 (+0.44%) ▲|SO96.61-0.18 (-0.18%) ▼|SPG237.02+0.32 (+0.13%) ▲|T24.43-0.24 (-0.95%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN269.88-7.19 (-2.60%) ▼|UBER70.50-0.24 (-0.34%) ▼|UNH424.70-4.09 (-0.95%) ▼|UNP291.95-2.50 (-0.85%) ▼|UPS105.04-0.49 (-0.46%) ▼|USB63.56-0.88 (-1.36%) ▼|V373.42+6.83 (+1.86%) ▲|VZ48.09-0.11 (-0.22%) ▼|WFC84.99-1.89 (-2.17%) ▼|WMT113.93+0.83 (+0.73%) ▲|XOM157.17+4.13 (+2.70%) ▲|AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX216.11-2.47 (-1.13%) ▼|SBUX104.11+1.01 (+0.97%) ▲|SCHW106.44+0.47 (+0.44%) ▲|SO96.61-0.18 (-0.18%) ▼|SPG237.02+0.32 (+0.13%) ▲|T24.43-0.24 (-0.95%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN269.88-7.19 (-2.60%) ▼|UBER70.50-0.24 (-0.34%) ▼|UNH424.70-4.09 (-0.95%) ▼|UNP291.95-2.50 (-0.85%) ▼|UPS105.04-0.49 (-0.46%) ▼|USB63.56-0.88 (-1.36%) ▼|V373.42+6.83 (+1.86%) ▲|VZ48.09-0.11 (-0.22%) ▼|WFC84.99-1.89 (-2.17%) ▼|WMT113.93+0.83 (+0.73%) ▲|XOM157.17+4.13 (+2.70%) ▲|
26.8 C
New York
Wednesday, July 29, 2026

Tag: revenues

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

AS Tallinna Sadam financial results for 2025 Q2 and 6 months

In the second quarter, Tallinna Sadam earned close to 30 million euros in sales revenue and more than 3 million euros in profit. The revenue for six months was 58 million euros and the profit exceeded 10 million euros. In the second quarter, the volume of investments increased to 8 million euros, in the first half of the year we invested a total of 12 million euros.

RDDT FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Reddit, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August...

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

XORTX Completes USD $114,500 Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES

Crown Capital Partners Announces Q2 2025 Financial Results

CALGARY, AB, Aug. 8, 2025 /CNW/ - Crown Capital Partners Inc. ("Crown" or the "Corporation") (TSX: CRWN) today announced its financial results for the...

Dorel Reports Second Quarter 2025 Results

MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the second quarter and six months ended June 30, 2025.

Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions

MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the first fiscal quarter ended June 30, 2025.

Parks! America, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results

Management to host conference call on Monday, August 11, 2025, at 4:30 PM ET

Spirit AeroSystems Announces Definitive Agreement with CTRM for Acquisition of Facility in Subang, Malaysia

WICHITA, Kan., Aug. 8, 2025 /PRNewswire/ -- Today, Spirit AeroSystems Holdings, Inc. (NYSE: SPR) announces a purchase agreement to sell its facility and businesses in...

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant –

Femasys Announces Second Quarter Financial Results for 2025

-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio --

ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the second quarter of 2025.

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates

JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRevenues